• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

治疗药物监测的最佳实践。

Best practice in therapeutic drug monitoring.

作者信息

Gross A S

机构信息

Department of Clinical Pharmacology, Royal North Shore Hospital, St Leonards NSW, Australia.

出版信息

Br J Clin Pharmacol. 1998 Aug;46(2):95-9. doi: 10.1046/j.1365-2125.1998.00770.x.

DOI:10.1046/j.1365-2125.1998.00770.x
PMID:9723816
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1873661/
Abstract

It is the goal of Therapeutic Drug Monitoring (TDM) to use drug concentrations to manage a patient's medication regimen and optimise outcome. Limited resources require that drug assays should only be performed when they do contribute to patient management. For this to be the case a therapeutic drug monitoring service has a far greater role than just therapeutic drug measuring. This article describes the roles and functions of a Best Practice TDM service. The features which can and should be strived for in each step of the TDM process-the decision to request a drug level, the biological sample, the request, laboratory measurement, communication of results by the laboratory, clinical interpretation and therapeutic management-are discussed.

摘要

治疗药物监测(TDM)的目标是利用药物浓度来管理患者的用药方案并优化治疗效果。资源有限,这就要求仅在药物检测有助于患者管理时才进行检测。要实现这一点,治疗药物监测服务的作用远不止于药物检测。本文描述了最佳实践TDM服务的作用和功能。文中讨论了TDM过程每个步骤中能够且应该追求的特征,即申请药物浓度检测的决定、生物样本、申请、实验室检测、实验室结果传达、临床解读以及治疗管理。

相似文献

1
Best practice in therapeutic drug monitoring.治疗药物监测的最佳实践。
Br J Clin Pharmacol. 1998 Aug;46(2):95-9. doi: 10.1046/j.1365-2125.1998.00770.x.
2
Best practice in therapeutic drug monitoring.治疗药物监测的最佳实践。
Br J Clin Pharmacol. 2001;52 Suppl 1(Suppl 1):5S-10S. doi: 10.1046/j.1365-2125.2001.0520s1005.x.
3
Therapeutic drug monitoring in a developing country: an overview.发展中国家的治疗药物监测:概述
Br J Clin Pharmacol. 2001;52 Suppl 1(Suppl 1):103S-108S. doi: 10.1046/j.1365-2125.2001.0520s1103.x.
4
Delivery of therapeutic drug monitoring services: survey of Australasian clinical pharmacology laboratories.治疗药物监测服务的提供:澳大利亚和新西兰临床药理实验室调查
Ther Drug Monit. 1998 Dec;20(6):598-601. doi: 10.1097/00007691-199812000-00002.
5
Clinical utility of drug measurement and pharmacokinetics: therapeutic drug monitoring in psychiatry.药物测量与药代动力学的临床应用:精神科的治疗药物监测
Eur J Clin Pharmacol. 2008 Feb;64(2):159-66. doi: 10.1007/s00228-007-0430-1. Epub 2008 Jan 15.
6
Current status of therapeutic drug monitoring in Australia and New Zealand: a need for improved assay evaluation, best practice guidelines, and professional development.澳大利亚和新西兰治疗药物监测的现状:需要改进检测评估、最佳实践指南和专业发展。
Ther Drug Monit. 2010 Oct;32(5):615-23. doi: 10.1097/FTD.0b013e3181ea3e8a.
7
Therapeutic drug monitoring in Turkey: experiences from Istanbul.土耳其的治疗药物监测:来自伊斯坦布尔的经验
Ther Drug Monit. 2000 Oct;22(5):545-8. doi: 10.1097/00007691-200010000-00007.
8
Appropriateness of therapeutic drug monitoring for lithium.锂盐治疗药物监测的适宜性
J Med Assoc Thai. 2006 Nov;89(11):1954-60.
9
[Therapeutic drug monitoring for supporting oncological treatments: a new era begins].
Magy Onkol. 2023 Jun 13;67(2):131-137. Epub 2023 Apr 28.
10
[Therapeutic monitoring: analytic, pharmacokinetic and clinical aspects].[治疗监测:分析、药代动力学及临床方面]
Acta Clin Belg. 1999;53 Suppl 1:2-12.

引用本文的文献

1
Novel High-Throughput Screen Identified S100A4 Inhibitors for Anti-Metastatic Therapy.新型高通量筛选鉴定出用于抗转移治疗的S100A4抑制剂。
Int J Biol Sci. 2025 Jul 11;21(10):4683-4700. doi: 10.7150/ijbs.113805. eCollection 2025.
2
Clinical relevance and methodological approach for the assessment of drug-drug interactions in cancer patients: a position statement from the Italian Association of Medical Oncology (AIOM) and the Italian Society of Pharmacology (SIF).癌症患者药物相互作用评估的临床相关性及方法学探讨:来自意大利医学肿瘤学协会(AIOM)和意大利药理学协会(SIF)的立场声明
ESMO Open. 2025 Jun;10(6):105119. doi: 10.1016/j.esmoop.2025.105119. Epub 2025 Jun 10.
3
Implementation and validation of a 24/7 system for the monitoring of antiepileptic drugs.一种用于监测抗癫痫药物的全天候系统的实施与验证
Front Neurol. 2025 Mar 14;16:1493201. doi: 10.3389/fneur.2025.1493201. eCollection 2025.
4
Integrated Electrochemical Aptamer Biosensing and Colorimetric pH Monitoring via Hydrogel Microneedle Assays for Assessing Antibiotic Treatment.基于水凝胶微针分析的电化学适体生物传感与比色 pH 监测整合用于评估抗生素治疗。
Adv Sci (Weinh). 2024 Nov;11(41):e2309027. doi: 10.1002/advs.202309027. Epub 2024 Sep 9.
5
Evaluation of Antimicrobial Resistancein Clinical Isolates of spp. Obtained from Hospital Patients in Latvia.评估从拉脱维亚医院患者中分离得到的 spp. 临床分离株的耐药性。
Medicina (Kaunas). 2024 May 23;60(6):850. doi: 10.3390/medicina60060850.
6
Bioanalytical technologies using temperature-responsive polymers.使用温度响应性聚合物的生物分析技术。
Anal Sci. 2024 May;40(5):827-841. doi: 10.1007/s44211-024-00545-3. Epub 2024 Apr 7.
7
Therapeutic Drug Monitoring (TDM) Implementation in Public Hospitals in Greece in 2003 and 2021: A Comparative Analysis of TDM Evolution over the Years.2003年和2021年希腊公立医院的治疗药物监测(TDM)实施情况:多年来TDM演变的比较分析
Pharmaceutics. 2023 Aug 23;15(9):2181. doi: 10.3390/pharmaceutics15092181.
8
Therapeutic Drug Monitoring by Pharmacists: Does It Reduce Costs.药剂师进行的治疗药物监测:它能降低成本吗?
Glob J Qual Saf Healthc. 2020 May 21;3(2):69-71. doi: 10.36401/JQSH-19-40. eCollection 2020 May.
9
Chromatography columns packed with thermoresponsive-cationic-polymer-modified beads for therapeutic drug monitoring.用热敏阳离子聚合物修饰珠体填充的色谱柱用于治疗药物监测。
Sci Rep. 2022 Jul 27;12(1):12847. doi: 10.1038/s41598-022-16928-3.
10
Would they accept it? An interview study to identify barriers and facilitators to user acceptance of a prescribing advice service.他们会接受吗?一项识别用户接受处方建议服务的障碍和促进因素的访谈研究。
BMC Health Serv Res. 2022 Apr 18;22(1):514. doi: 10.1186/s12913-022-07927-1.

本文引用的文献

1
Indications for plasma drug monitoring in patients with epilepsy. Implications for reducing costs.
Pharmacoeconomics. 1997 Apr;11(4):343-9. doi: 10.2165/00019053-199711040-00005.
2
Will routine therapeutic drug monitoring have a place in clozapine therapy?常规治疗药物监测在氯氮平治疗中会占有一席之地吗?
Clin Pharmacokinet. 1997 Feb;32(2):93-100. doi: 10.2165/00003088-199732020-00001.
3
Therapeutic drug monitoring databases for postmarketing surveillance of drug-drug interactions: evaluation of a paired approach for psychotropic medication.
Ther Drug Monit. 1997 Feb;19(1):1-10. doi: 10.1097/00007691-199702000-00001.
4
Drug monitoring in nonconventional biological fluids and matrices.非常规生物流体和基质中的药物监测。
Clin Pharmacokinet. 1996 Mar;30(3):211-28. doi: 10.2165/00003088-199630030-00003.
5
Antiepileptic drug monitoring: a reappraisal.抗癫痫药物监测:重新评估
Epilepsia. 1995;36 Suppl 5:S22-9. doi: 10.1111/j.1528-1157.1995.tb06006.x.
6
Measurement and analysis of unbound drug concentrations.游离药物浓度的测定与分析。
Clin Pharmacokinet. 1996 Jun;30(6):445-62. doi: 10.2165/00003088-199630060-00003.
7
Therapeutic drug monitoring for the treatment of psychiatric disorders. Clinical use and cost effectiveness.用于精神疾病治疗的治疗药物监测。临床应用与成本效益。
Clin Pharmacokinet. 1995 Dec;29(6):442-50. doi: 10.2165/00003088-199529060-00005.
8
Generation of pharmacokinetic data during routine therapeutic drug monitoring: Bayesian approach vs. pharmacokinetic studies.常规治疗药物监测期间药代动力学数据的生成:贝叶斯方法与药代动力学研究
Ther Drug Monit. 1993 Aug;15(4):281-8. doi: 10.1097/00007691-199308000-00004.
9
Concentration- or effect-controlled clinical trials with sparse data.
Clin Pharmacol Ther. 1994 Jul;56(1):1-8. doi: 10.1038/clpt.1994.93.
10
Therapeutic drug monitoring and patient outcome. A review of the issues.
Clin Pharmacokinet. 1994 Sep;27(3):169-74. doi: 10.2165/00003088-199427030-00001.